ロード中...
Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma
Crizotinib has been approved for patients with advanced lung adenocarcinoma harboring rearrangements of the c-ROS-1 (ROS1) and anaplastic lymphoma kinase (ALK) genes. We report a patient with ROS1-rearranged lung adenocarcinoma who developed a crizotinib-induced mixed/cholestatic type of liver injur...
保存先:
| 出版年: | Intern Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japanese Society of Internal Medicine
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6794186/ https://ncbi.nlm.nih.gov/pubmed/31178493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2554-18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|